Nadler WM - Search Results

1

Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.

Kuhlmann L, Nadler WM, Kerner A, Hanke SA, Noll EM, Eisen C, Espinet E, Vogel V, Trumpp A, Sprick MR, Roesli CP. Kuhlmann L, et al. Among authors: nadler wm. Pancreas. 2017 Mar;46(3):311-322. doi: 10.1097/MPA.0000000000000743. Pancreas. 2017. PMID: 27846146

2

The pivotal role of reactivity in the design of novel biotinylation reagents for the chemical-proteomics-based identification of vascular accessible biomarkers.

Hanke SA, Kerner A, Nadler WM, Trumpp A, Zhang Y, Rösli CP. Hanke SA, et al. Among authors: nadler wm. J Proteomics. 2016 Jun 1;141:57-66. doi: 10.1016/j.jprot.2016.04.014. Epub 2016 Apr 23. J Proteomics. 2016. PMID: 27113135

3

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Noll EM, Eisen C, Stenzinger A, Espinet E, Muckenhuber A, Klein C, Vogel V, Klaus B, Nadler W, Rösli C, Lutz C, Kulke M, Engelhardt J, Zickgraf FM, Espinosa O, Schlesner M, Jiang X, Kopp-Schneider A, Neuhaus P, Bahra M, Sinn BV, Eils R, Giese NA, Hackert T, Strobel O, Werner J, Büchler MW, Weichert W, Trumpp A, Sprick MR. Noll EM, et al. Nat Med. 2016 Mar;22(3):278-87. doi: 10.1038/nm.4038. Epub 2016 Feb 8. Nat Med. 2016. PMID: 26855150 Free PMC article.

4

MALDI versus ESI: The Impact of the Ion Source on Peptide Identification.

Nadler WM, Waidelich D, Kerner A, Hanke S, Berg R, Trumpp A, Rösli C. Nadler WM, et al. J Proteome Res. 2017 Mar 3;16(3):1207-1215. doi: 10.1021/acs.jproteome.6b00805. Epub 2017 Feb 15. J Proteome Res. 2017. PMID: 28176526

5

Ion source-dependent performance of 4-vinylpyridine, iodoacetamide, and N-maleoyl derivatives for the detection of cysteine-containing peptides in complex proteomics.

Nadler W, Berg R, Walch P, Hanke S, Baalmann M, Kerner A, Trumpp A, Roesli C. Nadler W, et al. Anal Bioanal Chem. 2016 Mar;408(8):2055-67. doi: 10.1007/s00216-015-9113-4. Epub 2015 Oct 22. Anal Bioanal Chem. 2016. PMID: 26493978

6

A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.

Blatnik R, Mohan N, Bonsack M, Falkenby LG, Hoppe S, Josef K, Steinbach A, Becker S, Nadler WM, Rucevic M, Larsen MR, Salek M, Riemer AB. Blatnik R, et al. Among authors: nadler wm. Proteomics. 2018 Jun;18(11):e1700390. doi: 10.1002/pmic.201700390. Epub 2018 May 2. Proteomics. 2018. PMID: 29603667 Free PMC article.

7

Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody.

Roider HG, Hoff S, Tseng SY, Berndt S, Trautwein M, Filarsky K, Gritzan U, Camps J, Nadler WM, Grudzinska-Goebel J, Ellinger P, Pesch T, Soon CF, Geyer M, Gluske K, Stelte-Ludwig B, Gorjánácz M. Roider HG, et al. Among authors: nadler wm. Clin Exp Med. 2024 Jun 10;24(1):122. doi: 10.1007/s10238-024-01362-8. Clin Exp Med. 2024. PMID: 38856863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page